RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Chicago, IL · Skokie, IL · +120 more sites
5 recruiting psoriasis studies with a site in Chicago, IL.
Sponsor: Bristol-Myers Squibb
Chicago, IL · Skokie, IL · +120 more sites
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +49 more sites
Sponsor: Duke University
Chicago, IL · +72 more sites
Sponsor: UCB Biopharma SRL
Chicago, IL · +29 more sites
Sponsor: Northwestern University
Chicago, IL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.